Tilray (TLRY) may be the cannabis winner
What’s up with Tilray?
Tilray (TLRY) opened at $7.95, which means the stock is down 1.11% from yesterday’s closing price of 8.11. Today, the company has a high of $8.75 and a low of $7.70. The company has a market cap of $885.75 million with a 52-week high of $52.74 and a 52-week low of $2.43.
What about the future forTilray
The high forecast for Tilray is 18.00 while the low is 2.00. Stock forecasts are based on human experience: Human traders based on their experience in terms of stock price patterns, volume changes, and market news/rumors regarding a particular stock. Tilray has a strong forecast. A strong forecast is a result of strong earning reports as investors are willing to pay a higher share price today because of growth expectations in the future.. Based on this information TLRY seems to be a safe buy.
Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment sales consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment sales consist of hemp seed, hemp foods, board spectrum hemp extract containing CBD which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.